Skip to main content
SpringerLink
Log in

Prevention and Control of Tobacco Use as a Major Risk Factor for Non-communicable Diseases (NCDS): A Lifecourse Approach

  • Chapter
  • First Online:
Healthy Lifestyle

Part of the book series: Integrated Science ((IS,volume 3))

Abstract

Tobacco use is responsible for approximately 8.7 million (6.5 million in men and 2.1 million in women) deaths across the world in 2019, majority of which occurr prematurely. In spite of such high death rates, there are more than 1.3 billion tobacco users (age 15 years and above) in the world, of which 80% reside in the LMICs. It is also estimated that 24 million children (between the ages of 13–15 years) smoke and 13 million use smokeless tobacco, globally. The behaviour of tobacco uptake and consumption is encompassed within various social, environmental, cultural and economic factors and impact people in all age groups. Factors, including sex, age, education and income are important predictors of all forms of tobacco use. This chapter explores the impact of tobacco on various non-communicable diseases such as cardiovascular diseases, respiratory diseases, cancers, oral health diseases and also comments on the implication of tobacco use in COVID-19 pandemic in all age groups. It further discusses the physiology of nicotine addiction and comments on the evidence available on the uptake of tobacco use. The chapter elaborates on various tobacco control measures that are available currently while also raising concerns brought on by introduction of new electronic nicotine delivery devices in the recent years. It is an overview of the tobacco epidemic presented through the lens of the prevalence of non-communicable diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Notes

  1. 1.

    FEV measures the amount of air that a person exhales through a forced breath. It is a lung function test to diagnose obstructive diseases of the lungs such as COPD. A person with COPD would usually have lower FEV1 result than a healthy person.

References

  1. World Health Organisation (2018) Noncommunicable diseases country profiles 2018. Available from: http://www.who.int/nmh/publications/ncd-profiles-2018/en/

  2. World Health Organization. Burden: mortality, morbidity and risk factors. Available from: https://www.who.int/nmh/publications/ncd_report_chapter1.pdf?ua=1

  3. Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P et al (2011) Priority actions for the non-communicable disease crisis. Lancet 377(9775):1438–1447

    Article  Google Scholar 

  4. Institute for Health Metrics and Evaluation. Global health Data. GBD Results Tool | GHDx. Available from: http://ghdx.healthdata.org/gbd-results-tool

  5. World Health Organization. Tobacco: key facts. Available from: https://www.who.int/news-room/fact-sheets/detail/tobacco

  6. World Health Organisation (2019) Report on the global tobacco epidemic, 2019: Offer help to quit tobacco use. Geneva

    Google Scholar 

  7. Goodchild M, Nargis N, d’Espaignet ET (2018) Global economic cost of smoking-attributable diseases. Tob Control 27(1):58–64

    Article  Google Scholar 

  8. United Nations Development Programme (2013) Discussion paper addressing the social determinants of noncommunicable diseases. pp 96–96. Available from: https://www.undp.org/content/dam/undp/library/hivaids/English/Discussion_Paper_Addressing_the_Social_Determinants_of_NCDs_UNDP_2013.pdf

  9. Grundy EJ, Suddek T, Filippidis FT, Majeed A, Coronini-Cronberg S (2020) Smoking, SARS-CoV-2 and COVID-19: a review of reviews considering implications for public health policy and practice. Tob Induc Dis 18

    Google Scholar 

  10. Benowitz NL (2010) Nicotine addiction. N Engl J Med 362(24):2295–2303

    Article  CAS  Google Scholar 

  11. Hoffmann D, Hoffmann I (1998) Chemistry and toxicology. Cigars Heal Eff trends Smok Tob Control Monogr 9:55–104

    Google Scholar 

  12. Picciotto MR, Mineur YS (2014) Molecules and circuits involved in nicotine addiction: the many faces of smoking. Neuropharmacology 76:545–553

    Article  CAS  Google Scholar 

  13. Prochaska JJ, Benowitz NL (2019) Current advances in research in treatment and recovery: nicotine addiction. vol. 5, Science Advances. American Association for the Advancement of Science. Available from: https://pubmed.ncbi.nlm.nih.gov/31663029/

  14. Samet JM, Yoon S-Y (2010) Gender, women, and the tobacco epidemic. World Health Organization

    Google Scholar 

  15. Koob GF, Le Moal M, Thompson RF (2010) Encyclopedia of behavioral neuroscience. Elsevier

    Google Scholar 

  16. Center for Disease Control and Prevention (2009) Cigarette smoking among adults and trends in smoking cessation-United States, 2008. MMWR Morb Mortal Wkly Rep 58(44):1227

    Google Scholar 

  17. Hughes JR (2007) Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob Res 9(3):315–327

    Article  Google Scholar 

  18. Weinberger AH, Desai RA, McKee SA (2010) Nicotine withdrawal in US smokers with current mood, anxiety, alcohol use, and substance use disorders. Drug Alcohol Depend 108(1–2):7–12

    Article  Google Scholar 

  19. Covey LS, Glassman AH, Stetner F (1998) Cigarette smoking and major depression. J Addict Dis 17(1):35–46

    Article  CAS  Google Scholar 

  20. Hall SM, Muñoz RF, Reus VI, Sees KL (1993) Nicotine, negative affect, and depression. J Consult Clin Psychol 61(5):761

    Article  CAS  Google Scholar 

  21. Xi B, Liang Y, Liu Y, Yan Y, Zhao M, Ma C et al (2016) Tobacco use and second-hand smoke exposure in young adolescents aged 12–15 years: data from 68 low-income and middle-income countries. Lancet Glob Heal. 4(11):e795–805. Available from: http://www.thelancet.com/lancetgh

  22. Kelder SH, Perry CL, Klepp KI, Lytle LL (1994) Longitudinal tracking of adolescent smoking, physical activity, and food choice behaviors. Am J Public Health. 7;84(7):1121–1126. Available from: http://ajph.aphapublications.org/

  23. Sharapova S, Reyes-Guzman C, Singh T, Phillips E, Marynak KL, Agaku I (2020) Age of tobacco use initiation and association with current use and nicotine dependence among US middle and high school students, 2014–2016. Tob Control 29(1):49–54, 1 Jan. Available from: https://tobaccocontrol.bmj.com/content/29/1/49

  24. Veeranki SP, John RM, Ibrahim A, Pillendla D, Thrasher JF, Owusu D et al (2017) Age of smoking initiation among adolescents in Africa. Int J Public Health 62(1):63–72. Available from: https://link.springer.com/article/10.1007/s00038-016-0888-7

  25. Centers for Disease Control and Prevention (1994) Preventing tobacco use among young people: a report of the surgeon general (Executive Summary). Available from: https://www.cdc.gov/mmwr/PDF/rr/rr4304.pdf

  26. Tucker JS, Ellickson PL, Klein DJ (2003) Predictors of the transition to regular smoking during adolescence and young adulthood. J Adolesc Heal 32(4):314–24. Available from: https://pubmed.ncbi.nlm.nih.gov/12667736/

  27. Sussman SY, Ames SL (viaf)36266815 (2008) Drug abuse : concepts, prevention, and cessation. Cambridge University Press, Cambridge ; New York. Available from: http://lib.ugent.be/catalog/rug01:001278017

  28. Mayhew KP, Flay BR, Mott JA (2000) Stages in the development of adolescent smoking. In: Drug and alcohol dependence. Drug Alcohol Depend, pp 61–81. Available from: https://pubmed.ncbi.nlm.nih.gov/10773438/

  29. Kasza KA, Edwards KC, Tang Z, Stanton CA, Sharma E, Halenar MJ et al (2020) Correlates of tobacco product initiation among youth and adults in the USA: findings from the PATH Study Waves 1–3 (2013–2016). Tob Control 29(Suppl 3):S191–S202. Available from: https://pubmed.ncbi.nlm.nih.gov/32321853/

  30. Kakde S, Bhopal RS, Jones CM (2012) A systematic review on the social context of smokeless tobacco use in the South Asian population: Implications for public health. vol. 126, Public Health. W.B. Saunders, pp 635–645

    Google Scholar 

  31. National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health (2012) Social, environmental, cognitive, and genetic influences on the use of tobacco among youth. Available from: https://www.ncbi.nlm.nih.gov/books/NBK99236/

  32. Scal P, Ireland M, Borowsky IW (2003) Smoking among American adolescents: a risk and protective factor analysis. J Commun Health 28(2):79–97. Available from: https://pubmed.ncbi.nlm.nih.gov/12705311/

  33. Audrain-McGovern J, Rodriguez D, Patel V, Faith MS, Rodgers K, Cuevas J (2006) How do psychological factors influence adolescent smoking progression? The evidence for indirect effects through tobacco advertising receptivity. Pediatrics 117(4):1216–1225. Available from: https://pubmed.ncbi.nlm.nih.gov/16585318/

  34. Boyle RG, Claxton AJ, Forster JL (1997) The role of social influences and tobacco availability on adolescent smokeless tobacco use. J Adolesc Heal 20(4):279–85. Available from: https://pubmed.ncbi.nlm.nih.gov/9098731/

  35. Tomar SL, Giovino GA (1998) Incidence and predictors of smokeless tobacco use among US youth. Am J Public Health 88(1):20–26. Available from: https://pubmed.ncbi.nlm.nih.gov/9584028/

  36. Hanafin J, Clancy L (2015) History of tobacco production and use. In: Karger S (ed) AG Progress in respiratory research. pp 1–18. Available from: https://www.karger.com/Article/FullText/369289

  37. U S Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health (2014) The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General, pp 1–36. Available from: papers2://publication/uuid/BB6C3612–32F2–4F7A-9B3C-6F005E8E64E1

    Google Scholar 

  38. U.S. Department of Health and Human Services (2010) How tobacco smoke causes disease: The biology and behavioral basis for smoking-attributable disease. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the surgeon general. Centers for Disease Control and Prevention (US), p 792. Available from: https://www.ncbi.nlm.nih.gov/books/NBK53017/

  39. Shiels MS, Katki HA, Freedman ND, Purdue MP, Wentzensen N, Trabert B et al (2014) Cigarette smoking and variations in systemic immune and inflammation markers. JNCI J Natl Cancer Inst 1;106(11). Available from: https://academic.oup.com/jnci/article-lookup/doi/10.1093/jnci/dju294

  40. Roy A, Rawal I, Jabbour S, Prabhakaran D (2017) Tobacco and cardiovascular disease: a summary of evidence. In: Cardiovascular, respiratory, and related disorders. The International Bank for Reconstruction and Development/The World Bank. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30212086

  41. Bartal M (2001) Health effects of tobacco use and exposure. vol. 56, Monaldi Arch Chest Dis

    Google Scholar 

  42. Gupta R, Gupta N, Khedar RS (2013) Smokeless tobacco and cardiovascular disease in low and middle income countries. Indian Heart J65(4):369–377. Available from: https://pubmed.ncbi.nlm.nih.gov/23992997/

  43. Bonnie RJ, Stratton K, Kwan LY (2015) The effects of tobacco use on health. 2015 Jul 23. Available from: https://www.ncbi.nlm.nih.gov/books/NBK310413/

  44. Vardavas CI, Nikitara K (2020) COVID-19 and smoking: a systematic review of the evidence. Tob Induc Dis 18(March), 20 Mar 2020

    Google Scholar 

  45. Soriano JB, Kendrick PJ, Paulson KR, Gupta V, Abrams EM, Adedoyin RA et al (2020) Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med 8(6):585–596, 1 Jun 2020. Available from: http://ghdx.healthdata.org

  46. World Health Organisation (2019) WHO highlights huge scale of tobacco-related lung disease deaths. Available from: https://www.who.int/news/item/29-05-2019-who-highlights-huge-scale-of-tobacco-related-lung-disease-deaths

  47. National Cancer Policy Forum; Board on Health Care Services; Institute of Medicine (2013) Reducing tobacco-related cancer incidence and mortality—Workshop summary. In: Washington (DC): National Academics Press (US); 2013. Available from: https://www.ncbi.nlm.nih.gov/books/NBK206898/

  48. Vineis P, Alavanja M, Buffler P, Fontham E, Franceschi S, Gao YT et al (2004) Tobacco and cancer: recent epidemiological evidence. JNCI J Natl Cancer Inst 96(2):99–106, 21 Jan 2004. Available from: https://academic.oup.com/jnci/article-lookup/doi/10.1093/jnci/djh014

  49. Chao A, Thun MJ, Jane Henley S, Jacobs EJ, McCullough ML, Calle EE (2002) Cigarette smoking, use of other tobacco products and stomach cancer mortality in US adults: The cancer prevention study II. Int J Cancer 101(4):380–389, 1 Oct 2002. Available from: https://pubmed.ncbi.nlm.nih.gov/12209964/

  50. Kristina SA, Permitasari NPAL, Krisnadewi KI, Santoso KA, Puspawati PR, Masrida WO et al (2019) Cancer attributable to tobacco smoking in member countries of association of Southeast Asian Nations (ASEAN) in Year 2018. Asian Pacific J Cancer Prev 20(10):2909–2915. Available from: /pmc/articles/PMC6982657/?report=abstract

    Google Scholar 

  51. Siddiqi K, Shah S, Abbas SM, Vidyasagaran A, Jawad M, Dogar O et al (2015) Global burden of disease due to smokeless tobacco consumption in adults: analysis of data from 113 countries. BMC Med 13(1):194, 17 Dec 2015. Available from: http://bmcmedicine.biomedcentral.com/articles/https://doi.org/10.1186/s12916-015-0424-2

  52. Asthana S, Labani S, Kailash U, Sinha DN, Mehrotra R. Association of smokeless tobacco use and oral cancer: a systematic global review and meta-analysis. Nicotine Tob Res 21(9):1162–1171, 19 Aug 2019. Available from: https://pubmed.ncbi.nlm.nih.gov/29790998/

  53. Akter S, Goto A, Mizoue T (2017) Smoking and the risk of type 2 diabetes in Japan: a systematic review and meta-analysis. J Epidemiol. Jpn Epidemiol Assoc 27:553–61. Available from: https://pubmed.ncbi.nlm.nih.gov/28716381/

  54. Peng K, Chen G, Liu C, Mu Y, Ye Z, Shi L et al (2018) Association between smoking and glycemic control in diabetic patients: results from the Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal (REACTION) study. J Diabetes. 10(5):408–418, 1 May 2018. Available from: https://pubmed.ncbi.nlm.nih.gov/29144059/

  55. Bott U, Jörgens V, Grüsser M, Bender R, Mühlhauser I, Berger M (1994) Predictors of glycaemic control in type 1 diabetic patients after participation in an intensified treatment and teaching programme. Diabet Med 11(4):362–371. Available from: https://pubmed.ncbi.nlm.nih.gov/8088108/

  56. Targher G, Alberiche M, Zenere MB, Bonadonna RC, Muggeo M, Bonora E (1997) Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus 1. J Clin Endocrinol Metab. 82(11):3619–3624, Nov 1997. Available from: https://pubmed.ncbi.nlm.nih.gov/9360516/

  57. Tschöpe D, Bramlage P, Binz C, Krekler M, Deeg E, Gitt AK (2012) Incidence and predictors of hypoglycaemia in type 2 diabetes—an analysis of the prospective DiaRegis registry. BMC Endocr Disord 12, 17 Oct 2012. Available from: https://pubmed.ncbi.nlm.nih.gov/23075070/

  58. Jiang X, Jiang X, Wang Y, Huang R (2019) Correlation between tobacco smoking and dental caries: a systematic review and meta-analysis [Internet], vol. 17. Tobacco Induced Diseases. International Society for the Prevention of Tobacco Induced Diseases. Available from: /pmc/articles/PMC6662788/?report=abstract

    Google Scholar 

  59. Golpasand Hagh L, Zakavi F, Ansarifar S, Ghasemzadeh O, Solgi G (2013) Association of dental caries and salivary sIgA with tobacco smoking. Aust Dent J [Internet]. [cited 2020 Dec 14] 58(2):219–23, 1 Jun 2013. Available from: http://doi.wiley.com/10.1111/adj.12059

  60. Tomar SL, Winn DM (1999) Chewing tobacco use and dental caries among U.S. men. J Am Dent Assoc 130(11):1601–1610, 1 Nov

    Google Scholar 

  61. Alamir AH, Quadri MFA (1957) Tobacco use and orofacial pain: a meta-analysis. Nicotine Tob Res [Internet]. [cited 2020 Dec 14] 22(11):1957–1963, 29 Oct 2020. Available from: https://academic.oup.com/ntr/article/22/11/1957/5831215

  62. Eisner MD, Klein J, Hammond SK, Koren G, Lactao G, Iribarren C (2005) Directly measured second hand smoke exposure and asthma health outcomes. Thorax [Internet]. [cited 2020 Dec 14] 60(10):814–821, 1 Oct 2005. Available from: www.thoraxjnl.com

  63. Gürkan F, Kiral A, Dali E, Karakoç F (2000) The effect of passive smoking on the development of respiratory syncytial virus bronchiolitis. Eur J Epidemiol [Internet]. 16(5):465–468, [cited 14 Dec 2020]. Available from: https://pubmed.ncbi.nlm.nih.gov/10997834/

  64. Adair-Bischoff CE, Sauve RS (1998) Environmental tobacco smoke and middle ear disease in preschool-age children. Arch Pediatr Adolesc Med [Internet]. 152(2):127–133, [cited 14 Dec 2020]. Available from: https://pubmed.ncbi.nlm.nih.gov/9491037/

  65. Mannino DM, Siegel M, Husten C, Rose D, Etzel R (1996) Environmental tobacco smoke exposure and health effects in children: results from the 1991 national health interview survey. Tob Control [Internet]. 5(1):13–18, 20 Mar 1996 [cited 14 Dec 2020]. Available from: http://tobaccocontrol.bmj.com/

  66. Kabir Z, Manning PJ, Holohan J, Keogan S, Goodman PG, Clancy L (2009) Second-hand smoke exposure in cars and respiratory health effects in children. Eur Respir J [Internet] 34(3):629–633, 1 Sep 2009 [cited 14 Dec 2020]. Available from: www.erj.erjournals.com

  67. Zairina E (2016) Maternal passive smoking and the risk of developing wheeze in children: How should we deal with it? [Internet]. vol. 48, Eur Respir J Eur Respir Soc 2016 [cited 14 Dec 2020]. pp 3–5. Available from: http://ow.ly/hdm5300ExJ5

  68. Gilliland FD, Li YF, Peters JM (2001) Effects of maternal smoking during pregnancy and environmental tobacco smoke on asthma and wheezing in children. Am J Respir Crit Care Med [Internet] 163(2):429–436, 2001 [cited 14 Dec 2020]. Available from: https://pubmed.ncbi.nlm.nih.gov/11179118/

  69. Taylor B, Wadsworth J (1987) Maternal smoking during pregnancy and lower respiratory tract illness in early life. Arch Dis Child [Internet]. 1 Aug 1987 [cited 14 Dec 2020] 62(8):786–791. Available from: http://adc.bmj.com/

  70. Herrmann M, King K, Weitzman M (2008) Prenatal tobacco smoke and postnatal secondhand smoke exposure and child neurodevelopment. Current Opin Pediatr 20:184–190

    Google Scholar 

  71. Centers for Disease Control and Prevention. health effects of secondhand smoke. Available from: https://www.cdc.gov/tobacco/data_statistics/fact_sheets/secondhand_smoke/health_effects/index.htm

  72. Mitchell EA, Ford RPK, Stewart AW, Taylor BJ, Becroft DMO, Thompson JMD et al (1993) Smoking and the sudden infant death syndrome. Pediatrics 91(5)

    Google Scholar 

  73. Petrick LM, Svidovsky A, Dubowski Y (2011) Thirdhand smoke: Heterogeneous oxidation of nicotine and secondary aerosol formation in the indoor environment. Environ Sci Technol [Internet] 45(1):328–333, 1 Jan 2011 [cited 15 Dec 2020]. Available from: https://pubmed.ncbi.nlm.nih.gov/21141815/

  74. Northrup TF, Jacob P, Benowitz NL, Hoh E, Quintana PJE, Hovell MF et al (2016) Thirdhand smoke: state of the science and a call for policy expansion. Publ Health Rep [Internet]. 131(2):233–238, 1 Mar 2016 [cited 15 Dec 2020]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765971/

  75. Matt GE, Quintana PJE, Destaillats H, Gundel LA, Sleiman M, Singer BC et al (2011) Thirdhand tobacco smoke: Emerging evidence and arguments for a multidisciplinary research agenda [Internet]. Environ Health Perspect. Environ Health Perspect 2011 [cited 15 Dec 2020]. 119:1218–1226. Available from: https://pubmed.ncbi.nlm.nih.gov/21628107/

  76. Centers for Disease Control and Prevention (2020) Benefits of quitting: smoking & tobacco use [Internet]. [cited 15 Dec 2020]. Available from: https://www.cdc.gov/tobacco/quit_smoking/how_to_quit/benefits/index.htm

  77. World Health Organization. Guidelines for implementation of Article 14. Available from: https://www.who.int/fctc/guidelines/adopted/article_14/en/

  78. Silagy C, Lancaster T, Stead L, Mant D, Fowler G (2004) Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 3(3)

    Google Scholar 

  79. Benowitz NL (1993) Nicotine replacement therapy. Drugs 45(2):157–170

    Article  CAS  Google Scholar 

  80. Benowitz NL, Gourlay SG (1997) Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol 29(7):1422–1431

    Article  CAS  Google Scholar 

  81. Moore D, Aveyard P, Connock M, Wang D, Fry-Smith A, Barton P (2009) Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis. BMJ 338:b1024–b1024

    Article  Google Scholar 

  82. Cahill K, Lindson‐Hawley N, Thomas KH, Fanshawe TR, Lancaster T (2016) Nicotine receptor partial agonists for smoking cessation. Cochrane database Syst Rev (5)

    Google Scholar 

  83. World Health Organization (2003) WHO framework convention on tobacco control [Internet]. 2003. p 42. Available from: https://www.who.int/fctc/text_download/en/

  84. World Health Organization. MPOWER measures [Internet]. Available from: https://www.who.int/tobacco/mpower/en/

  85. Chaloupka FJ, Yurekli A, Fong GT (2012) Tobacco taxes as a tobacco control strategy. Tob Control 21(2):172–180

    Article  Google Scholar 

  86. Townsend J, Roderick P, Cooper J (1994) Cigarette smoking by socioeconomic group, sex, and age: effects of price, income, and health publicity. BMJ 309(6959):923–927

    Article  CAS  Google Scholar 

  87. Goenka S, Tewari A, Arora M, Stigler MH, Perry CL, Arnold JPS et al (2010) Process evaluation of a tobacco prevention program in Indian schools-methods, results and lessons learnt. Health Educ Res [Internet]. 25:917–935. Available from: internal-pdf://80.194.98.0/Goenka-2010-Processevaluationofatobaccopr.pdf

    Google Scholar 

  88. World Health Organisation. Enforce bans on tobacco advertising, promotion and sponsorship. Available from: https://www.who.int/tobacco/mpower/enforce/en/

  89. DiFranza JR, Wellman RJ, Sargent JD, Weitzman M, Hipple BJ, Winickoff JP (2006) Tobacco promotion and the initiation of tobacco use: assessing the evidence for causality. Pediatrics 117(6):e1237–e1248

    Article  Google Scholar 

  90. Arora M, Gupta VK, Nazar GP, Stigler MH, Perry CL, Reddy K nath (2012) Impact of tobacco advertisements on tobacco use among urban adolescents in India: results from a longitudinal study. Tob Control [Internet]. 21(3):318–324. Available from: internal-pdf://0029088815/Arora-2012-Impactoftobaccoadvertisementsonpdf

    Google Scholar 

  91. Arora M, Nazar GP, Chugh A, Rawal T, Shrivastava S, Sinha P et al (2020) Tobacco imagery in on-demand streaming content popular among adolescents and young adults in India: Implications for global tobacco control. Tob Control

    Google Scholar 

  92. U.S Department of Health and Human Services (2012). Preventing tobacco use among youth and young adults: a report of the surgeon general [Internet]. Atlanta; [cited 2 Jun 2020]. Available from: http://www.surgeongeneral.gov/library

  93. Wakefield M, Coomber K, Zacher M, Durkin S, Brennan E, Scollo M (2015) Australian adult smokers’ responses to plain packaging with larger graphic health warnings 1 year after implementation: results from a national cross-sectional tracking survey. Tob Control 24(Suppl 2):ii17–25

    Google Scholar 

  94. U S Department of Health and Human Services National Center for Chronic Disease Prevention and Health Promotion. Surgeon general’s advisory on e-cigarette use among youth [Internet]. Available from: https://e-cigarettes.surgeongeneral.gov/

  95. Goniewicz ML, Gawron M, Nadolska J, Balwicki L, Sobczak A (2014) Rise in electronic cigarette use among adolescents in Poland. J Adolesc Heal 55(5):713–715

    Article  Google Scholar 

  96. Wagoner KG, Cornacchione J, Wiseman KD, Teal R, Moracco KE, Sutfin EL (2016) E-cigarettes, hookah pens and vapes: adolescent and young adult perceptions of electronic nicotine delivery systems. Nicotine Tob Res 18(10):2006–2012

    Article  Google Scholar 

  97. Shrivastav R, Kathuria P, Arora M, Munish VG, Sinha P, Tullu FT (2018) (Mis)perceptions related to Electronic Nicotine Delivery Systems (ENDS) and hookah: Making a case for policy strengthening through a multi-stakeholder qualitative study from New Delhi, India. Tob Induc Dis [Internet].16:178–179. Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L627399380%0Ahttp://dx.doi.org/https://doi.org/10.18332/tid/84580

  98. Callahan-Lyon P (2014) Electronic cigarettes: human health effects. Tob Control 23(suppl 2):ii36–40

    Google Scholar 

  99. Schneider S, Diehl K (2016) Vaping as a catalyst for smoking? An initial model on the initiation of electronic cigarette use and the transition to tobacco smoking among adolescents. Nicotine Tob Res 18(5):647–653

    Article  Google Scholar 

  100. National Center for Chronic Disease Prevention and Health Promotion. Electronic cigarettes. Available from: https://www.cdc.gov/tobacco/basic_information/e-cigarettes/index.htm

  101. Goriounova NA, Mansvelder HD (2012) Short-and long-term consequences of nicotine exposure during adolescence for prefrontal cortex neuronal network function. Cold Spring Harb Perspect Med 2(12):a012120–a012120

    Article  Google Scholar 

  102. World Health Organization. Background papers to the WHO report on electronic nicotine delivery systems and electronic non-nicotine delivery systems (ENDS) [Internet]. Available from: https://www.who.int/tobacco/industry/product_regulation/eletronic-cigarettes-report-cop7-background-papers/en/

Download references

Author information

Authors and Affiliations

  1. HRIDAY, New Delhi, India

    Aastha Chugh & Monika Arora

  2. Public Health Foundation of India, Haryana, India

    Neha Jain & Monika Arora

Authors
  1. Aastha Chugh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Neha Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Monika Arora
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Monika Arora .

Editor information

Editors and Affiliations

  1. Pediatrics Department and USERN Office, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran

    Roya Kelishadi

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Chugh, A., Jain, N., Arora, M. (2022). Prevention and Control of Tobacco Use as a Major Risk Factor for Non-communicable Diseases (NCDS): A Lifecourse Approach. In: Kelishadi, R. (eds) Healthy Lifestyle. Integrated Science, vol 3. Springer, Cham. https://doi.org/10.1007/978-3-030-85357-0_9

Download citation

Publish with us

Policies and ethics

Search

Navigation